Shareholders' Equity

12 Months Ended

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

Shareholders' Equity [Text Block]

Shareholders' Equity

Accumulated Other Comprehensive Loss

The following table presents the changes in Accumulated other comprehensive loss, excluding noncontrolling interests:

	Foreign Currency Translation Adjustment and Other, Net		Unrealized Gain (Loss) on Foreign Exchange Contracts Designated as Net Investment Hedges, Net		Unrealized Gain (Loss) on Interest Rate Swaps Designated as Cash Flow Hedges, Net		Employee Benefit Plan Items, Net		Total
Balance as of December 31, 2019	$	(245,705)	$	10,368	$	(13,347)	$	(13,527)	$	(262,211)
Other comprehensive income (loss) before reclassifications (a)	183,636		(6,802)		(12,023)		(4,882)		159,929
Amounts reclassified into income (loss)	(958)		(6,686)		3,023		2,018		(2,603)
Net change in accumulated other comprehensive income (loss) for the year ended December 31, 2020	182,678		(13,488)		(9,000)		(2,864)		157,326
Balance as of December 31, 2020	(63,027)		(3,120)		(22,347)		(16,391)		(104,885)
Other comprehensive income (loss) before reclassifications (a)	(127,931)		21,133		19,232		4,223		(83,343)
Amounts reclassified into income (loss)	(1,981)		(6,681)		2,306		2,927		(3,429)
Net change in accumulated other comprehensive income (loss) for the year ended December 31, 2021	(129,912)		14,452		21,538		7,150		(86,772)
Balance as of December 31, 2021	$	(192,939)	$	11,332	$	(809)	$	(9,241)	$	(191,657)

(a)     Foreign currency translation adjustment includes intra-entity foreign currency transactions that are of a long-term investment nature of $(9,981) and $31,470 for 2021 and 2020, respectively.

Common Stock Outstanding Activity

The following table sets forth the activity in the number of shares outstanding (in thousands):

	Common Stock Issued	Treasury Stock	Common Stock Outstanding
Common stock outstanding at December 31, 2018	125,424	40,233	85,191
Shares issued for stock-based compensation awards	—	(886)	886
Repurchases of common stock	—	5,457	(5,457)
Common stock outstanding at December 31, 2019	125,424	44,804	80,620
Shares issued for stock-based compensation awards	—	(764)	764
Repurchases of common stock	—	6,541	(6,541)
Common stock outstanding at December 31, 2020	125,424	50,581	74,843
Shares issued for stock-based compensation awards	—	(1,056)	1,056
Repurchases of common stock	—	7,833	(7,833)
Common stock outstanding at December 31, 2021	125,424	57,358	68,066

The company has 2,000,000 authorized shares of serial preferred stock with a par value of one dollar. There were no shares of serial preferred stock outstanding at December 31, 2021 and 2020.

Share-Repurchase Programs

The following table shows the company's Board of Directors (the “Board”) approved share-repurchase programs as of December 31, 2021:

Month of Board Approval	Dollar Value Approved for Repurchase		Dollar Value of Shares Repurchased		Approximate Dollar Value of Shares that May Yet be Purchased Under the Program
December 2018	$	600,000	$	600,000	$	—
July 2020	600,000		600,000		—
July 2021	600,000		436,532		163,468
December 2021	600,000		—		600,000
Total	$	2,400,000	$	1,636,532	$	763,468